Safety and Efficacy of Using the New Tissue Containment System During Laparoscopic Myomectomy Morcellation

Safety and Efficacy of Using the New Tissue Containment System With Hard Pipes Which Can Assemble With Detachable Trocars Seamlessly for Tissue Removal During Laparoscopic Myomectomy Morcellation

The study is designed to evaluate the safety of performing the new tissue containment system during laparoscopic myomectomy morcellation. Pre- and perimenopausal women, aged 18-45 undergoing laparoscopic myomectomy morcellation

Inclusion Criteria:

• Pre- and Peri-menopausal woman patient age 18-45 years

  • Women with fibroids and indication for laparoscopic myomectomy.
  • Normal Pap smear result within one year
  • MRI ( Magnatic Resonance Imaging ) or other imaging findings indicate the diameter of the largest uterine fibroids is between 4 to 10cm.
  • The body mass index of the patients is 18.5-27.9kg/m2
  • Signed informed consent form

Exclusion Criteria:

• • Women with Known or suspected malignancy

  • patients with severe pelvic adhesion found during the operation
  • The body mass index of the patient ≥ 28kg/m2
  • Diameter of a single uterine fibroid>10cm
  • patients during pregnancy and lactation
  • Known blood diseases, bleeding coagulation disease, any part of the active bleeding or bleeding tendency of the constitution of the patient
  • Patients with known severe liver and kidney dysfunction;Liver function (ALT, AST) ≥ 2 times of normal upper limit, or renal function (Cr) ≥ normal upper limit
  • Patients who are known to have participated in any other clinical trial within 3 months
  • Patients who cannot sign informed consent
  • Patients with acute stage infection of the reproductive system or other sites